Many pro-angiogenic factors mediate tumour angiogenesis, and among these, VEGFa might play a major role in the process through which ACE2 inhibits breast cancer angiogenesis, as demonstrated through our database analysis. The gene discussed is VEGFA; the disease is breast cancer.